Reliance Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LENALIDOMIDE, with a corresponding US DMF Number 27905.
Remarkably, this DMF maintains an Active status since its submission on February 03, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 23, 2023, and payment made on February 13, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II